Havencrest Capital Management
Private equityDallas · Growth · 56 people tracked
Investment thesis
Havencrest is a lower middle-market private equity fund dedicated to the healthcare sector, backing and building companies that transform how healthcare is delivered in America. Its portfolio spans clinical trial site networks, healthcare staffing, post-acute and home-based care, behavioral and mental health, and hospice and palliative care. The firm partners with established healthcare businesses to expand access to high-quality patient care across select markets and facility types, including integrated delivery networks and acute care hospitals.
Source: firm website, verified Aug 6, 2026.
Team · 56 people
from the firm's websiteWhat they invest in
from 4 of 29 portfolio companiesBiotech ×3Healthtech ×1Medical Devices ×1
HQs:United States×3
Investments · 29 tracked
founders shown can be your intro pathMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients, including oncology, hematology, and autoimmune applications.
BiotechMedical Devices
Clinical-stage biopharmaceutical company developing topical products for pain management.
National provider of rehabilitative services for offenders and management services for correctional and detention facilities.
Enables clinical teams to leverage EMR technologies for high-quality care, documentation and operational efficiency.
Medical product company using NMR technology to develop diagnostic tests for cardiovascular, metabolic and other diseases.
Provides medical waste removal, destruction and related environmental services to healthcare providers.
Industry-leading private-equity backed CDMO focused on development and manufacturing of cutting-edge biopharmaceuticals
BiotechBaltimore, US
Marco Chacon(Executive Officer, Director)Patrick Hervy(Director)Christopher Kersey(Director)Kapila Ratnam(Director)Peter Buzy(Executive Officer)
Building a network of 24-hour, state-of-the-art veterinary hospitals.
Fund performance · per public LP disclosures
as of Nov 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Havencrest Healthcare Partners Fund II, L.PLPs: Employees' Retirement System of Rhode Island | 2022 | — | -8.6% | 0.85x | 0.02x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What stage does Havencrest Capital Management invest at?
- Havencrest Capital Management invests at the Growth stage.
- What sectors does Havencrest Capital Management focus on?
- Havencrest Capital Management focuses on Digital Health, Healthtech, Mental Health.
- Where is Havencrest Capital Management located?
- Havencrest Capital Management is headquartered in Dallas, US.
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Catalyst is a growth-stage investment firm providing growth capital to B2B businesses, offering strategic, tactical and financial support to help companies scale.
Flare Capital Partners is a venture capital firm specializing in healthcare technology, backing founders building software, data, and AI infrastructure for the healthcare industry.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Equitage Ventures is an early-stage investor focused on companies addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.